According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is -1,51ย โฌ. In 2022 the company made an earnings per share (EPS) of -1,82ย โฌ an increase over its 2021 EPS that were of -2,65ย โฌ.